Clinical trial
Worldwide One-year Open-label Safety Study of Flibanserin in Women With HSDD
NCT00441558 is registered in ClinicalTrials.gov with Sprout Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Worldwide One-year Open-label Safety Study of Flibanserin in Women With HSDD
- Lead sponsor
- Sprout Pharmaceuticals, Inc
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 28, 2007
- Completion date
- August 31, 2009
- Enrollment
- 1,723 (actual)
- Sites
- 196
Conditions
As the registry lists them; a condition with its own page is linked.